drugset

drugset / Trial / NCT01664013

The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients

NCT01664013 ↗

Phase 4 Unknown 20 enrolled Roongroj Bhidayasiri

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the impact of botulinum toxin treatment in quality of life(QoL) in cervical dystonia patients

Timeline

Start: 2012-10
Primary completion: 2013-10
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nuronox	Protein / enzyme biologic	—	—

Indications